196 related articles for article (PubMed ID: 32048928)
21. [Adolescents and young adults with acute lymphoblastic leukemia. A specific management].
Boissel N; Ducassou S
Bull Cancer; 2017; 104(7-8):683-689. PubMed ID: 28576259
[TBL] [Abstract][Full Text] [Related]
22. Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?
Boissel N; Baruchel A
Blood; 2018 Jul; 132(4):351-361. PubMed ID: 29895662
[TBL] [Abstract][Full Text] [Related]
23. Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020.
Rank CU; Schmiegelow K
Semin Hematol; 2020 Jul; 57(3):102-114. PubMed ID: 33256899
[TBL] [Abstract][Full Text] [Related]
24. Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults.
Litzow MR
Hematology Am Soc Hematol Educ Program; 2009; ():362-70. PubMed ID: 20008222
[TBL] [Abstract][Full Text] [Related]
25. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
26. [Current treatment of adult acute lymphoblastic leukemia].
Fujisawa S
Rinsho Ketsueki; 2017; 58(10):1983-1994. PubMed ID: 28978840
[TBL] [Abstract][Full Text] [Related]
27. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041
[TBL] [Abstract][Full Text] [Related]
28. Progress in the treatment of adults with acute lymphoblastic leukemia.
Larson S; Stock W
Curr Opin Hematol; 2008 Jul; 15(4):400-7. PubMed ID: 18536580
[TBL] [Abstract][Full Text] [Related]
29. [Safety and efficacy of CD19-targeted CAR-T cells in 14 patients with refractory/relapsed Philadelphia chromosome-positive acute B-precursor lymphoblastic leukemia].
He CX; Xue L; Qiang P; Xu H; Zhang XH; Liu X; Zhu WW; Cai XY; Liu HL; Sun ZM; Wang XB
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):490-494. PubMed ID: 32654463
[No Abstract] [Full Text] [Related]
30. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
McNeer JL; Bleyer A
Pediatr Blood Cancer; 2018 Jun; 65(6):e26989. PubMed ID: 29418064
[TBL] [Abstract][Full Text] [Related]
31. Adolescents and young adults with acute lymphoblastic leukemia.
Stock W
Hematology Am Soc Hematol Educ Program; 2010; 2010():21-9. PubMed ID: 21239766
[TBL] [Abstract][Full Text] [Related]
32. Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study.
Muffly L; Alvarez E; Lichtensztajn D; Abrahão R; Gomez SL; Keegan T
Blood Adv; 2018 Apr; 2(8):895-903. PubMed ID: 29669756
[TBL] [Abstract][Full Text] [Related]
33. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
DeAngelo DJ
Hematology Am Soc Hematol Educ Program; 2005; ():123-30. PubMed ID: 16304369
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children.
Aldoss IT; Marcucci G; Pullarkat V
Oncology (Williston Park); 2016 Dec; 30(12):1080-91. PubMed ID: 27987201
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells.
Gu B; Shi BY; Zhang X; Zhou SY; Chu JH; Wu XJ; Fu CC; Qiu HY; Han Y; Chen SN; Yu L; Ma X; Wu DP
Bone Marrow Transplant; 2021 Jan; 56(1):91-100. PubMed ID: 32581286
[TBL] [Abstract][Full Text] [Related]
36. Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options.
Khan M; Siddiqi R; Tran TH
Semin Hematol; 2018 Oct; 55(4):235-241. PubMed ID: 30502852
[TBL] [Abstract][Full Text] [Related]
37. Acute lymphoblastic leukemia.
Alvarnas JC; Brown PA; Aoun P; Ballen KK; Bellam N; Blum W; Boyer MW; Carraway HE; Coccia PF; Coutre SE; Cultrera J; Damon LE; DeAngelo DJ; Douer D; Frangoul H; Frankfurt O; Goorha S; Millenson MM; O'Brien S; Petersdorf SH; Rao AV; Terezakis S; Uy G; Wetzler M; Zelenetz AD; Naganuma M; Gregory KM;
J Natl Compr Canc Netw; 2012 Jul; 10(7):858-914. PubMed ID: 22773801
[TBL] [Abstract][Full Text] [Related]
38. How we approach Philadelphia chromosome-positive acute lymphoblastic leukemia in children and young adults.
Slayton WB; Schultz KR; Silverman LB; Hunger SP
Pediatr Blood Cancer; 2020 Oct; 67(10):e28543. PubMed ID: 32779849
[TBL] [Abstract][Full Text] [Related]
39. Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.
Schultz KR; Devidas M; Bowman WP; Aledo A; Slayton WB; Sather H; Zheng HW; Davies SM; Gaynon PS; Trigg M; Rutledge R; Jorstad D; Carroll AJ; Heerema N; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B;
Leukemia; 2014 Apr; 28(4):964-7. PubMed ID: 24434862
[No Abstract] [Full Text] [Related]
40. Olverembatinib in relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: a study of 5 cases.
Liu C; Zhang X; Mao L; Qian J; Xiao F; Ye X; Wei J; Ye X; Jin J; Yu W
Leuk Lymphoma; 2023 Jun; 64(6):1208-1211. PubMed ID: 37067187
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
